<DOC>
	<DOCNO>NCT01261052</DOCNO>
	<brief_summary>The purpose research study test automate blood glucose control system include new component design adapt stress . The importance component Type 1 Diabetics stress ( example , illness infection ) , body resistant effect insulin . The investigator adjust blood glucose use insulin glucagon make body less sensitive insulin steroid , hydrocortisone . Insulin hormone lower blood glucose . Glucagon raise blood glucose low . Both natural hormone make people without diabetes . Hydrocortisone steroid increase blood glucose temporarily give every 4 hour . All subject participate two 33 hour experiment . One experiment use adaptive version sensor-based glucose control system . The study use original version control system , without adaptive component , first 13 hour . Then , adaptive component add glucose control system remain 20 hour study . Our primary goal ass effectiveness adaptive component control glucose level presence steroid-induced insulin resistance person Type 1 Diabetes Mellitus .</brief_summary>
	<brief_title>Real-time Adaptation Changes Insulin Sensitivity</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<criteria>Diagnosis Type 1 Diabetes Mellitus least 1 year Male Female subject 21 65 year age Willingness follow study procedure , include attend clinic visit Willingness sign inform consent HIPAA document . Pregnancy Lactation : For woman childbearing potential : requirement negative urine pregnancy test agreement use contraception study least 1 month participate study . Acceptable contraception include birth control pill / patch / vaginal ring , DepoProvera , Norplant , IUD , double barrier method ( woman use diaphragm spermicide man use condom ) , abstinence . Renal insufficiency ( serum creatinine 2.0 mg/dL great ) . Serum ALT AST equal great 3 time upper limit normal ; hepatic synthetic insufficiency define serum albumin le 3.3 g/dL ; serum bilirubin 2 . Adrenal insufficiency Hematocrit le equal 34 % . A history cerebrovascular disease coronary artery disease regardless time since occurrence . Congestive heart failure , NYHA class III IV . Cardiac rhythm disturbance characterize : 2nd 3rd degree heart block , bradycardia le 50 bpm ( exception bradycardia aerobic athlete ) , tachycardia great 100 bpm , arrhythmia judge investigator exclusionary . Any active infection . Visual impairment prevent read glucose meter value continuous glucose monitoring device . Physical impairment impede ability use glucose meter glucose monitoring device . Active foot ulceration . Severe peripheral arterial disease characterize ischemic rest pain severe claudication . Active alcohol abuse , substance abuse , severe mental illness ( judge principal investigator ) . Active malignancy , except basal cell squamous cell skin cancer . Major surgical operation within 30 day prior screen . Seizure disorder . Any concurrent illness , diabetes , control stable therapeutic regimen . Chronic usage immunosuppressive medication ( cyclosporine , azathioprine , sirolimus , tacrolimus ) . Current administration oral parenteral corticosteroid . Use investigational drug within 30 day prior screen . Bleeding disorder , treatment warfarin , platelet count 50,000 . History major noncompliance . Allergy aspart insulin . Allergy glucagon . Past history pheochromocytoma family history MEN 2 , neurofibromatosis , von HippelLindau disease . Insulin resistance require 200 unit per day . Need uninterrupted treatment acetaminophen . Intolerance mild hypoglycemia ( glucose 6070 mg/dl ) . Patients use dietary supplement ( except vitamin supplement , calcium vitamin D standard dos ) . Patients history glaucoma ophthalmologic exam previous 2 year ( risk increase intraocular pressure ) Patients history psychiatric disease steroidinduced psychosis . Patients currently estrogen supplementation ( low dose estrogen contraceptive exclusionary ) . Chronic use dietary supplement contain adrenal cell extract , adrenal cortical extract , hormone . The use dietary supplement ( except vitamin supplement , calcium vitamin D standard dos ) exclusionary ( unless subject agree abstain take supplement three week begin study . Administration immunization ( flu travel immunization ) plan receive immunization within one week begin study . Any reason principal investigator deem exclusionary .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>glucose sensor</keyword>
	<keyword>artificial pancreas</keyword>
	<keyword>Diabetes Mellitus</keyword>
</DOC>